Use access key #2 to skip to page content.

Closing CYCC (Cyclacel) underperform



March 24, 2008 – Comments (0)

I'm closing this underperform pick which has performed well for me largely due to the small cap biotech sector swoon rather than any specific negative catalyst. The stock is now barely trading above cash and could pop with positive interim results, even though I think long-term prospects of the company are very poor. I think the best strategy to maximize my CYCC points is to let it pop then rate it underperform again.

0 Comments – Post Your Own

Featured Broker Partners